https://www.fiercepharma.com/pharma/game-abbvie-roches-columvi-nabs-fda-approval-2nd-bispecific-large-b-cell-lymphoma
0
0
Game on, AbbVie. Roche's Columvi nabs FDA nod as 2nd bispecific for large B-cell lymphoma - FiercePharma
6/16/23 at 2:49pm
Organization
FiercePharma
Author
FiercePharma
Details
18 words
Summarize
Create an account or login to join the discussion